GenVivo
Home
About
About Us
Our Leadership
Our Organization
Platform
Pipeline
News
Publications
Press Releases
Careers
Contact
Home
About
About Us
Our Leadership
Our Organization
Platform
Pipeline
News
Publications
Press Releases
Careers
Contact
text
Press Releases
LATEST NEWS
GenVivo Latest News
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a Personalizing, Gene Vector Immunotherapy, in Patients with Advanced Solid Tumors
Jun 27, 2024
Read More >
GenVivo to Present Pipeline Programs at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 8, 2024
Read More >
GenVivo to Present at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Apr 10, 2024
Read More >
GenVivo to Present at the 2024 BioProcess International (BPI) US West Annual Meeting
Mar 12, 2024
Read More >
GenVivo to Present at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 4, 2023
Read More >
GenVivo to Present at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 19, 2023
Read More >
up